← Back to Search

Electronic Pillbox Monitoring System for Medication Adherence

Phase 1 & 2
Waitlist Available
Led By Connie M Trinacty, PhD
Research Sponsored by Harvard Pilgrim Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

The objective of this pilot study is to explore barriers to medication adherence among HPHC members with CKD, particularly those not yet on dialysis, and to assess the feasibility and acceptability of a wireless, internet-based MedMinder system intervention among HPHC enrollees with CKD and their care partners. The investigators hypothesize that the intervention will improve medication use and adherence among patient members with CKD on complex medication treatment, and improve informal caregivers' ability to provide support for improved medication use among patient members.

Eligible Conditions
  • Medication Adherence
  • Chronic Kidney Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
medication adherence

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Electronic Pillbox Monitoring SystemExperimental Treatment1 Intervention
Usual care plus receive use of the wireless electronic pillbox and medication monitoring system
Group II: Usual CareActive Control1 Intervention
Usual care patients will have outpatient care and monitoring procedures, as determined by them and their health care providers.

Find a Location

Who is running the clinical trial?

Harvard Pilgrim Health CareLead Sponsor
55 Previous Clinical Trials
27,790,918 Total Patients Enrolled
Connie M Trinacty, PhDPrincipal InvestigatorHarvard Medical School and Harvard Pilgrim Health Care Institute
Ashley J Beard, PhDStudy DirectorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025